Physics-Informed Neural Networks Show Promise for Estimating Hidden Drug Concentrations in Chemotherapy
Researchers benchmarked Physics-Informed Neural Networks (PINNs) against standard clinical methods for estimating drug concentrations in chemotherapy pharmacokinetics, where tissue drug levels cannot be directly measured. PINNs matched or exceeded traditional approaches and revealed fundamental identifiability problems that standard methods mask. The work suggests PINNs could improve drug dosing by better estimating tissue exposure, which determines both tumor kill and toxicity.
A new study published on arXiv compares Physics-Informed Neural Networks (PINNs)—machine learning models that incorporate known physics equations—against standard clinical methods for estimating drug concentrations during chemotherapy. The problem is practically important: plasma drug levels are routinely measured, but tissue concentrations, which determine therapeutic efficacy and toxicity, cannot be directly observed. On standard linear two-compartment models, PINNs matched the clinical baseline (nonlinear least-squares fitting) while also estimating tissue curves in a single training pass, whereas a data-only neural network failed by roughly 10-fold. More significantly, when the researchers tested a more complex model with saturable drug elimination (Michaelis-Menten kinetics), the standard clinical method became mathematically mis-specified and returned meaningless parameters, while the PINN honestly exposed that the model is non-identifiable from plasma measurements alone. Adding sparse tissue observations substantially improved identifiability, with the PINN recovering most parameters within acceptable ranges. The authors argue PINNs offer a uniform framework that matches traditional methods on standard problems while exposing hidden structural limitations and flexibly incorporating heterogeneous measurements.
What's missing
The study does not discuss computational cost or training time comparisons between PINNs and traditional methods, nor does it address clinical validation or prospective testing in actual patient populations. The work is a methodological benchmark on synthetic or historical data; translation to clinical practice would require additional validation steps.
What different sources said
- arXiv stat.MLCenter
Physics-Informed Neural Networks for Chemotherapy Pharmacokinetics: Benchmarking the Clinical Estimator and Exposing Parameter Identifiability
Related
Topology-Aware Thermodynamics Improves DNA Probe Specificity Design
Researchers developed a new framework for designing DNA probes that accounts for the spatial organization of matched sequences, not just overall thermodynamic stability. Traditional methods rely on scalar measures like melting temperature and free energy, which miss how mismatches are distributed along the probe. The approach could improve diagnostic accuracy in applications like HPV detection and gene expression profiling.
Study Identifies Optimal Thermal Dose for Combining Focused Ultrasound with Immunotherapy in Tumors
Researchers used multimodal PET imaging to identify an optimal thermal dose range for focused ultrasound ablation that destroys tumor tissue while preserving conditions for immunotherapy delivery. The study found that excessive heating collapses blood vessels needed for antibody access, while insufficient heating fails to adequately reduce tumor burden. The findings could guide clinical design of combination treatments pairing thermal ablation with immunotherapies.
Plant MSH1 Protein Functions as Mismatch-Directed Nuclease for Organelle Genome Maintenance
Researchers have identified the precise mechanism by which the AtMSH1 protein in Arabidopsis plants recognizes and cleaves DNA mismatches and lesions, preventing mutations in organellar genomes. The protein combines a DNA mismatch recognition module with a nuclease domain that makes staggered cuts at specific positions relative to DNA damage. This discovery explains how plants maintain unusually low mutation rates in their mitochondrial and chloroplast DNA compared to other eukaryotes.